全球DNA定序市场规模、份额、趋势和成长分析报告（2026-2034年）

DNA定序市场预计将从2025年的193亿美元成长到2034年的1,173.4亿美元，预计从2026年到2034年将以22.21%的复合年增长率成长。

受基因组研究和生物技术进步的推动，全球DNA定序市场经历了显着成长。 DNADNA测序技术使科学家能够精确定位遗传物质中核苷酸的序列，从而加深对生物过程和疾病的理解。这些技术广泛应用于医学研究、药物研发、农业和个人化医疗等领域。

DNA定序市场的主要驱动因素包括基因组研究的增加和精准医疗需求的成长。医疗专业人员和研究人员正在利用定序技术来识别基因突变并开发标靶治疗。此外，定序成本的降低和资料分析工具的改进也使得这些技术更容易被实验室和研究机构所采用。

随着基因组医学的不断发展，DNA定序市场依然前景看好。定序速度、准确性和成本的提升有望扩大其在临床诊断和医疗领域的应用。生物技术和生命科学研究投入的增加预计将进一步加速创新和市场成长。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章 全球DNA定序市场：依产品及服务划分

• 市场分析、洞察与预测
• 消耗品
• 装置
• 服务

第五章 全球DNA定序市场：依技术划分

• 市场分析、洞察与预测
• 桑格法
• 次世代定序（全基因测序(WGS)、全EXOME定序(WES)、标靶定序与定序）
• 第三代DNA定序（单分子即时定序（SMRT）、奈米孔定序）

第六章 全球DNA定序市场：依工作流程划分

• 市场分析、洞察与预测
• 序列预处理
• 定序
• 数据分析

第七章 全球DNA定序市场：依应用领域划分

• 市场分析、洞察与预测
• 肿瘤学
• 生殖健康
• 临床研究
• 农业基因组学与法医学
• HLA型检测/免疫系统监测
• 总体基因体学、流行病学和药物发现
• 消费者基因体学
• 其他的

第八章 全球DNA定序市场：依最终用途划分

• 市场分析、洞察与预测
• 学术研究
• 临床研究
• 医院和诊所
• 製药和生物技术公司
• 其他用户

第九章 全球DNA定序市场：依地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第十章 竞争格局

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第十一章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Thermo Fisher Scientific, Inc
  • Agilent Technology
  • IlluminaInc
  • QIAGEN
  • F. Hoffmann-La Roche Ltd
  • MacrogenInc
  • PerkinElmer Genomics
  • PacBio
  • BGI
  • Bio-Rad LaboratoriesInc
  • Myriad Genetics
  • PierianDx
  • Partek Incorporated
  • Eurofins Scientific

The DNA Sequencing Market size is expected to reach USD 117.34 Billion in 2034 from USD 19.30 Billion (2025) growing at a CAGR of 22.21% during 2026-2034.

The global DNA sequencing market has experienced significant growth due to advancements in genomic research and biotechnology. DNA sequencing technologies allow scientists to determine the precise order of nucleotides in genetic material, enabling deeper understanding of biological processes and diseases. These technologies are widely used in medical research, drug discovery, agriculture, and personalized medicine.

Key drivers of the DNA sequencing market include increasing research in genomics and rising demand for precision medicine. Healthcare providers and researchers use sequencing technologies to identify genetic mutations and develop targeted treatments. Declining sequencing costs and improvements in data analysis tools have also made these technologies more accessible to laboratories and research institutions.

The future prospects of the DNA sequencing market remain highly promising as genomic medicine continues to evolve. Advances in sequencing speed, accuracy, and affordability may expand its use in clinical diagnostics and healthcare. Growing investments in biotechnology and life sciences research are expected to further accelerate innovation and market growth.

MARKET SEGMENTATION

By Product & Services

• Consumables
• Instruments
• Services

By Technology

• Sanger Sequencing
• Next-Generation SequencingA (Whole Genome Sequencing (WGS), Whole Exome Sequencing (WES), Targeted Sequencing & Resequencing)
• Third Generation DNA SequencingA (Single-Molecule Real-Time Sequencing (SMRT), Nanopore Sequencing)

By Workflow

• Pre-sequencing
• Sequencing
• Data Analysis

By Application

• Oncology
• Reproductive Health
• Clinical Investigation
• Agrigenomics & Forensics
• HLA Typing/Immune System Monitoring
• Metagenomics, Epidemiology & Drug Development
• Consumer Genomics
• Others

By End-use

• Academic Research
• Clinical Research
• Hospitals & Clinics
• Pharmaceutical & Biotechnology Companies
• Other Users

COMPANIES PROFILED

• Thermo Fisher Scientific, Inc, Agilent Technology, Illumina, Inc, QIAGEN, F HoffmannLa Roche Ltd, Macrogen, Inc, PerkinElmer Genomics, PacBio, BGI, BioRad Laboratories, Inc, Myriad Genetics, PierianDx, Partek Incorporated, Eurofins Scientific
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL DNA SEQUENCING MARKET: BY PRODUCT & SERVICES 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product & Services
• 4.2. Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL DNA SEQUENCING MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Technology
• 5.2. Sanger Sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Next-Generation Sequencing (Whole Genome Sequencing (WGS), Whole Exome Sequencing (WES), Targeted Sequencing & Resequencing) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Third Generation DNA Sequencing (Single-Molecule Real-Time Sequencing (SMRT), Nanopore Sequencing) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL DNA SEQUENCING MARKET: BY WORKFLOW 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Workflow
• 6.2. Pre-sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Data Analysis Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL DNA SEQUENCING MARKET: BY APPLICATION 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Application
• 7.2. Oncology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Reproductive Health Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Clinical Investigation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Agrigenomics & Forensics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.6. HLA Typing/Immune System Monitoring Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.7. Metagenomics, Epidemiology & Drug Development Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.8. Consumer Genomics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.9. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL DNA SEQUENCING MARKET: BY END-USE 2022-2034 (USD MN)

• 8.1. Market Analysis, Insights and Forecast End-use
• 8.2. Academic Research Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.3. Clinical Research Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.4. Hospitals & Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.5. Pharmaceutical & Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.6. Other Users Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL DNA SEQUENCING MARKET: BY REGION 2022-2034 (USD MN)

• 9.1. Regional Outlook
• 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.2.1 By Product & Services
  • 9.2.2 By Technology
  • 9.2.3 By Workflow
  • 9.2.4 By Application
  • 9.2.5 By End-use
  • 9.2.6 United States
  • 9.2.7 Canada
  • 9.2.8 Mexico
• 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.3.1 By Product & Services
  • 9.3.2 By Technology
  • 9.3.3 By Workflow
  • 9.3.4 By Application
  • 9.3.5 By End-use
  • 9.3.6 United Kingdom
  • 9.3.7 France
  • 9.3.8 Germany
  • 9.3.9 Italy
  • 9.3.10 Russia
  • 9.3.11 Rest Of Europe
• 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.4.1 By Product & Services
  • 9.4.2 By Technology
  • 9.4.3 By Workflow
  • 9.4.4 By Application
  • 9.4.5 By End-use
  • 9.4.6 India
  • 9.4.7 Japan
  • 9.4.8 South Korea
  • 9.4.9 Australia
  • 9.4.10 South East Asia
  • 9.4.11 Rest Of Asia Pacific
• 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.5.1 By Product & Services
  • 9.5.2 By Technology
  • 9.5.3 By Workflow
  • 9.5.4 By Application
  • 9.5.5 By End-use
  • 9.5.6 Brazil
  • 9.5.7 Argentina
  • 9.5.8 Peru
  • 9.5.9 Chile
  • 9.5.10 Rest of Latin America
• 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.6.1 By Product & Services
  • 9.6.2 By Technology
  • 9.6.3 By Workflow
  • 9.6.4 By Application
  • 9.6.5 By End-use
  • 9.6.6 Saudi Arabia
  • 9.6.7 UAE
  • 9.6.8 Israel
  • 9.6.9 South Africa
  • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

• 10.1. Recent Developments
• 10.2. Company Categorization
• 10.3. Supply Chain & Channel Partners (based on availability)
• 10.4. Market Share & Positioning Analysis (based on availability)
• 10.5. Vendor Landscape (based on availability)
• 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL DNA SEQUENCING INDUSTRY

• 11.1. Top Companies Market Share Analysis
• 11.2. Company Profiles
  • 11.2.1 Thermo Fisher Scientific, Inc
  • 11.2.2 Agilent Technology
  • 11.2.3 IlluminaInc
  • 11.2.4 QIAGEN
  • 11.2.5 F. Hoffmann-La Roche Ltd
  • 11.2.6 MacrogenInc
  • 11.2.7 PerkinElmer Genomics
  • 11.2.8 PacBio
  • 11.2.9 BGI
  • 11.2.10 Bio-Rad LaboratoriesInc
  • 11.2.11 Myriad Genetics
  • 11.2.12 PierianDx
  • 11.2.13 Partek Incorporated
  • 11.2.14 Eurofins Scientific